Last Updated: May 10, 2026

Suppliers and packagers for CHLORAPREP ONE-STEP


✉ Email this page to a colleague

« Back to Dashboard


CHLORAPREP ONE-STEP

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832 NDA CareFusion 213, LLC 54365-400-07 48 POUCH in 1 CARTON (54365-400-07) / 1 APPLICATOR in 1 POUCH / 1.75 mL in 1 APPLICATOR 2019-05-24
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832 NDA CareFusion 213, LLC 54365-400-08 40 POUCH in 1 CARTON (54365-400-08) / 3 APPLICATOR in 1 POUCH / 1.75 mL in 1 APPLICATOR 2019-05-24
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832 NDA CareFusion 213, LLC 54365-400-37 1 APPLICATOR in 1 POUCH (54365-400-37) / 26 mL in 1 APPLICATOR 2019-05-24
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832 NDA CareFusion 213, LLC 54365-400-38 1 APPLICATOR in 1 POUCH (54365-400-38) / 26 mL in 1 APPLICATOR 2019-05-24
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832 NDA CareFusion 213, LLC 54365-400-39 1 APPLICATOR in 1 POUCH (54365-400-39) / 26 mL in 1 APPLICATOR 2019-05-24
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832 NDA CareFusion 213, LLC 54365-400-34 25 POUCH in 1 CARTON (54365-400-34) / 1 APPLICATOR in 1 POUCH / 10.5 mL in 1 APPLICATOR 2019-05-24
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Chloraprep One-Step

Last updated: July 30, 2025

Introduction

Chloraprep One-Step is a widely used antiseptic solution containing chlorhexidine gluconate and isopropyl alcohol, primarily employed for skin disinfection prior to surgical procedures, injections, and catheter insertions. Its effectiveness in reducing microbial load and preventing infections has cemented its position in hospitals, outpatient clinics, and procedural settings globally. Consequently, the manufacturing and supply of Chloraprep One-Step involve a complex network of pharmaceutical and chemical suppliers, manufacturing firms, and distribution channels.

This comprehensive analysis delves into the primary suppliers involved in the production of Chloraprep One-Step, scrutinizes their roles within the supply chain, and examines market dynamics shaping the availability and pricing of the product.

Manufacturers of Chloraprep One-Step

1. Ethicon Inc. (A Johnson & Johnson Company)

Ethicon, a Johnson & Johnson subsidiary, is the original developer and exclusive manufacturer of Chloraprep One-Step. The product was introduced by Ethicon as part of its suite of surgical antiseptics, capitalizing on J&J’s extensive healthcare distribution network. Ethicon’s manufacturing facilities, primarily situated in the United States, undergo rigorous quality control processes aligned with FDA and ISO standards, ensuring consistent product efficacy and safety.

Supply Chain Role:
Ethicon controls the proprietary formulation, packaging, and distribution of Chloraprep One-Step. Given its exclusivity, most supply disruptions are directly tied to Ethicon’s manufacturing capacity and inventory management.

2. Contract Manufacturing Organizations (CMOs)

While Ethicon holds the patent and manufacturing rights globally, third-party contract manufacturers play an auxiliary role, especially in contexts of increased demand or product expansion. Some pharmaceutical CMOs possess capabilities for sterile manufacturing of antiseptics and disinfectants, potentially producing generic formulations or bulk ingredients used in Chloraprep.

Notable CMOs involved in sterile pharmaceutical manufacturing include:

  • Baxter BioPharma: Known for sterile injectables and antiseptic solutions.
  • Recipharm: Offers sterile manufacturing services that could be adapted for antiseptic production.

However, it is crucial to note that Ethicon appears to produce Chloraprep in-house, with little publicly available evidence of active external manufacturing partnerships for the final product.

3. Raw Material Suppliers

The key active ingredients in Chloraprep are:

  • Chlorhexidine gluconate
  • Isopropyl alcohol

The supply of these raw materials significantly influences product availability.

a. Chlorhexidine Gluconate Suppliers

Major suppliers of chlorhexidine gluconate include:

  • McKesson Medical-Surgical Inc.: A leading distributor of pharmaceutical ingredients.
  • Siegfried AG: A global manufacturer of active pharmaceutical ingredients (APIs), including chlorhexidine components.
  • Fuso Pharmaceutical Industries: Japanese company providing high-purity chlorhexidine APIs.

b. Isopropyl Alcohol Suppliers

Top suppliers of pharmaceutical-grade isopropyl alcohol encompass:

  • Shell Chemicals: Produces high-purity isopropyl alcohol used in antiseptics.
  • ExxonMobil: Supplies a significant volume of isopropyl alcohol for medical and industrial applications.
  • Sasol Ltd.: Offers various grades of isopropyl alcohol globally.

These suppliers predominantly operate in Asia, Europe, and North America, with supply chains often affected by regional regulations, raw material costs, and geopolitical factors.

4. Packaging Material Suppliers

Packaging involves sterile, sealed bottles, and alcohol-resistant materials. Major suppliers include:

  • Berry Global: Provides pharmaceutical-grade plastic bottles and closures.
  • Amcor: Supplies flexible and rigid packaging solutions compliant with pharmaceutical standards.
  • WestRock: Offers specialized pharmaceutical packaging solutions conforming to regulatory requirements.

The quality and integrity of packaging are critical to product stability, especially for antiseptics with alcohol content.

Distribution and Logistics

Once manufactured, Cholaprep One-Step is distributed globally through Ethicon’s distribution network. Major logistical partners include:

  • McKesson Corporation
  • AmerisourceBergen
  • Cardinal Health

These firms handle warehousing, regional distribution, and inventory management, ensuring timely supply to healthcare providers. Internationally, distributors may interface with regional partners familiar with local regulations, import tariffs, and customs procedures.

Market Dynamics Impacting Supply

Global Raw Material Constraints

The production of chlorhexidine gluconate and isopropyl alcohol requires high-quality raw materials, often sourced from regions with fluctuating supply conditions. Recent disruptions, such as those caused by the COVID-19 pandemic or geopolitical tensions, have led to shortages and price volatility.

Regulatory Approvals and Quality Standards

Manufacturers must comply with strict regulatory standards, including the FDA’s Current Good Manufacturing Practice (CGMP) guidelines and international standards (ISO 13485, WHO prequalification). Regulatory compliance impacts supply continuity and shapes the manufacturing landscape.

Patent and Licensing Considerations

Johnson & Johnson’s patent rights to Chloraprep One-Step restrict production to authorized manufacturers. However, in regions where patent exclusivity has expired or is under challenge, generic formulations may be produced by other firms, diversifying supply sources.

Market Competition and Generic Alternatives

While Ethicon remains the sole producer of the proprietary formulation, generic antiseptics with similar efficacy are available from multiple suppliers. These alternatives influence market prices, demand, and supply stability.

Emerging Trends and Future Outlook

  • Innovation in Raw Materials: Development of biocompatible, less volatile raw material sources could stabilize supply.
  • Localized Manufacturing: Regions investments in local production facilities reduce dependency on global supply chains.
  • Supply Chain Diversification: Strategic stockpiling and supplier diversification mitigate risks related to raw material shortages and geopolitical disruptions.

Key Takeaways

  • Ethicon, a Johnson & Johnson subsidiary, is the principal manufacturer and exclusive supplier of Chloraprep One-Step.
  • Raw material suppliers—including McKesson, Siegfried, Shell Chemicals, ExxonMobil—are critical to the production continuity of Chloraprep.
  • Regional suppliers for packaging materials and logistics partners play vital roles in ensuring product availability.
  • Supply chain disruptions stem from raw material shortages, regulatory hurdles, and geopolitical factors, impacting global supply stability.
  • Moving toward localized manufacturing and diversified supplier bases represents key strategies to mitigate future supply risks.

FAQs

1. Who are the main manufacturers of Chloraprep One-Step?
Ethicon Inc., a subsidiary of Johnson & Johnson, is the primary and exclusive manufacturer of Chloraprep One-Step globally.

2. Can other companies produce generic equivalents of Chloraprep?
While the proprietary formulation is exclusive to Ethicon, generic antiseptics with similar active ingredients are available from multiple manufacturers, especially in regions where patent protections have expired.

3. What raw materials are essential for manufacturing Chloraprep?
Chlorhexidine gluconate and isopropyl alcohol are the core raw ingredients supplied by various chemical and pharmaceutical companies worldwide.

4. How do global supply chain disruptions affect Chloraprep availability?
Disruptions in raw material supply, transportation delays, or regulatory issues can lead to shortages or increased prices, affecting global supply.

5. Are there regional suppliers for Chloraprep components?
Regional suppliers for raw materials and packaging materials exist but are often linked to the overall global supply chain and subject to regional regulations and logistics infrastructure.

References

  1. Johnson & Johnson. (2022). Ethicon Chloraprep One-Step Product Information.
  2. FDA. (2021). Guidance for Industry – Current Good Manufacturing Practice (CGMP) for Combination Products.
  3. Siegfried AG. (2022). Global Active Pharmaceutical Ingredient Supply Chain Overview.
  4. Shell Chemicals. (2022). Pharmaceutical-grade Isopropyl Alcohol Product Data.
  5. McKesson Corporation. (2022). Supply Chain and Distribution Insights for Medical Supplies.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.